Home/Filings/4/0001209191-23-002542
4//SEC Filing

Race Geoffrey 4

Accession 0001209191-23-002542

CIK 0001566373other

Filed

Jan 8, 7:00 PM ET

Accepted

Jan 9, 4:04 PM ET

Size

7.7 KB

Accession

0001209191-23-002542

Insider Transaction Report

Form 4
Period: 2022-07-29
Transactions
  • Exercise/Conversion

    Common Stock

    2022-07-29$0.11/sh+3,937$4333,937 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2022-07-293,9373,937 total
    Exercise: $0.11Exp: 2029-12-18Common Stock (3,937 underlying)
Footnotes (3)
  • [F1]This Report is reporting the exempt exercise of employee stock options for cash payment thereof and receipt of the resulting shares. No shares were sold incidental to the exercise of these stock options.
  • [F2]This exercise price was originally reported incorrectly as $0.08 per share due to a conversion rate error from Pound Sterling into U.S. Dollars. Using the August 2022 approximate exchange rate of 1.2211, the exercise price in U.S. Dollars would be approximately $0.11 per share.
  • [F3]Shall vest in 12 equal monthly installments so long as he remains a director of the company.

Issuer

F-star Therapeutics, Inc.

CIK 0001566373

Entity typeother

Related Parties

1
  • filerCIK 0001831607

Filing Metadata

Form type
4
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 4:04 PM ET
Size
7.7 KB